New endocrine observations in a male patient with choriocarcinoma.
D000328:Adult; D001932:Brain Neoplasms / Q000134:cerebrospinal fluid; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002822:Choriocarcinoma / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D003951:Diagnostic Errors; D004958:Estradiol / Q000097:blood* / Q000134:cerebrospinal fluid; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008175:Lung Neoplasms / Q000175:diagnosis; D007986:Luteinizing Hormone / Q000097:blood / Q000134:cerebrospinal fluid; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010634:Phenobarbital / Q000627:therapeutic use; D013739:Testosterone / Q000097:blood* / Q000134:cerebrospinal fluid; D014750:Vincristine / Q000627:therapeutic use
D002556:Cerebrospinal Fluid Proteins; D003609:Dactinomycin; D013739:Testosterone; D004958:Estradiol; D014750:Vincristine; D003907:Dexamethasone; D003520:Cyclophosphamide; D007986:Luteinizing Hormone; D008525:Medroxyprogesterone; D006854:Hydrocortisone; D008727:Methotrexate; D010634:Phenobarbital